$Novavax(NVAX)$look at the options expiring on31/12 and you'll know why the SP is at this range. We have FDA filling by this week (if Stan kept hisword). Hopefully there's a positive jump on that. Otherwise it's a 2022 play.
I think people are having higher expectations of $Novavax(NVAX)$now. Looking at revenue and inventory specifically. That will reveal in 2022.Next positive catalysts:•FDA submission and approval•Omicron dataGoodluck to all longs!